Publications

O’Rand MG, Lea IA. 1997. Designing an effective immunocontraceptive. J Reprod Immunol 36(1–2):51–59; Review.

Adoyo PA, Lea IA, Richardson RT, Widgren EE, O’Rand MG. 1997. Sequence and characterization of the sperm protein Sp17 from the baboon. Mol Reprod Dev 47(1):66–71.

Kelsh MA, Sahl JD. 1997. Mortality among a cohort of electric utility workers 1960–1991. Am J Ind Med 31:534–544.

Ramu K, Perry CS, Ahmed T, Pakenham G, and Kehrer JP. 1996. Studies on the basis for the toxicity of acrolein mercapturates. Toxicol Appl Pharmacol 140(2):487-498.

Sauers L and Perry C.1996. Regulatory affairs – a growing opportunity for toxicologists. SOT Communiqué, May/June 1996.

Choksi NY, Kodavanti PRS, Tilson H, Booth RG. 1996. Effects of polychlorinated biphenyls on brain tyrosine hydroxylase activity in rats. Fundam Appl Toxicol 39:76–80, DOI: 10.1006/faat.1997.2351.

Hochberg F, Miller G, Valenzuela R, McNelis S, Crump KS, Covington T, Valdivia G, Hochberg B, Trustman JW. 1996. Late motor deficits of Chilean manganese miners: A blinded control study. Neurology 47:788–795.

Allen BC, Covington TR, Clewell HJ III. 1996. Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform. Toxicology 111:289–303.

Choksi NY, Hussain A, Booth RG. 1996. 2-Phenylaminoadenosine stimulates adenylyl cyclase activity and dopamine biosynthesis through an A2 receptor mediated mechanism. Brain Res 761:151–155, DOI: 10.1016/s0006-8993(97)00445-9.

Lea IA, Richardson RT, Widgren EE, O’Rand MG. 1996. Cloning and sequencing of cDNAs encoding the human sperm protein, Sp17. Biochim Biophys Acta 1307(3):263–266.

Huber KM, Mauk MD, Thompson CM, and Kelly PT. 1995. A critical period of protein kinase activity after tetanic stimulation is required for the induction of long-term potentiation. Learning & Memory. 2, 81–100.

Perry CS, Liu XL, Lund LG, and Kehrer JP. 1995. Differential toxicities of cyclophosphamide and its glutathione metabolites to A549 cells. Toxicol in Vitro 9:21-26.

Norton JN, Rylander LA, Richards JL. 1995. In vitro oral mucosa irritation testing with human cell cultures. Toxicol In Vitro 9(1):67–74.

Vater ST, Velazquez SF, Cogliano VJ. 1995. A case study of cancer data set combinations for PCBs. Regul Toxicol Pharmacol 22:2–10.

Gargas M, Norton R, Harris MA, Paustenbach D, Finley B. 1994. Urinary excretion of chromium following ingestion of chromite ore processing residue in humans: Implications for biomonitoring. Risk Anal 14(6):1019-1024.

Haws LC, Jackson BA, Turnbull D, and Dressler WE. 1994. Two approaches for assessing human cancer risk from disperse blue 1. Reg Toxicol Pharmacol. 19:80-96.

Rish W. 1994. SEC Initiatives in environmental disclosure: How can environmental liability be estimated? Ohio Environmental Law Letter 4(6):3–4.

Sahl JD, Kelsh MA, Smith RW, Aseltine DA. 1994. Exposure to 60 Hz magnetic fields in the electric utility work environment. Bioelectromagnetics 15(1):21-32. https://doi.org/10.1002/bem.2250150107

Copeland TL, Paustenbach DJ, Harris MA, and Otani J. 1993. Comparing the results of a Monte Carlo analysis with EPA’s reasonable maximum exposed individual (RMEI): a case study of a former wood treatment site. Reg Toxicol Pharmacol. 18:275-312.

Harris, MA, Zacharewski T, and Safe S. 1993. Comparative potencies of Aroclors 1232, 1248, 1254, and 1260 in male wistar rats—Assessment of the toxic equivalency factor (TEF) approach for polychlorinated biphenyls (PCBs). Fund Appl Toxicol. 20:456-463.